Darapladib, an inhibitor of Lp-PLA2, sensitizes cancer cells to ferroptosis by remodeling lipid metabolism https://www.biorxiv.org/content/10.1101/2023.04.08.536136v1?med=mas
Darapladib, an inhibitor of Lp-PLA2, sensitizes cancer cells to ferroptosis by remodeling lipid metabolism https://www.biorxiv.org/content/10.1101/2023.04.08.536136v1?med=mas